Overview A medical technology company based in Australia, Cleo Diagnostics (ASX:COV) is revolutionising women’s healthcare with its disruptive cancer detection platform technology, through a simple blood test that can accurately detect ovarian cancer early – the leading cause of cancer-related deaths among women. Approximately 50 percent of women will die…
Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the Clean Energy & Precious…
Altech Batteries Limited (Altech/the Company) (ASX: ATC) provides the following update regarding its Share Purchase Plan (SPP) as announced…
Element 25 Limited (E25 or Company) (ASX: E25; OTCQX: ELMTF) will offer eligible shareholders the opportunity to participate in…
Premier1 Lithium Limited (ASX:PLC) (“Premier1” or the “Company”) is pleased to announce the commencement of fieldwork at its Yalgoo…
With widespread adoption expected to continue across various industries, the robotics sector is projected to see major growth in…
In a bid to enhance the North American critical minerals supply chain, the Canadian and US governments announced a…
Sierra Nevada Gold (ASX: SNX) is pleased to announce plans to follow up drill hole BHD006 which returned up…
Global central banks own about 17 percent of all the gold ever mined, with reserves topping 36,699 metric tons…